| scholarly article | Q13442814 |
| P2093 | author name string | Fang Wang | |
| Shuai Yang | |||
| Tianshu Yang | |||
| Linxinyu Xu | |||
| P2860 | cites work | Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1) | Q35885013 |
| Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo | Q39412061 | ||
| Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity | Q41963390 | ||
| P433 | issue | 4 | |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 563-574 | |
| P577 | publication date | 2014-01-22 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | High-mobility group box-1 and its role in angiogenesis | |
| P478 | volume | 95 |
| Q38868613 | Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells |
| Q85914546 | Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma |
| Q26782785 | DAMPs from Cell Death to New Life |
| Q40104873 | Effect of high mobility group box 1 on the human retinal pigment epithelial cell in high-glucose condition |
| Q33874452 | Expression of High-Mobility Group Box 1 Protein (HMGB1) and Toll-Like Receptor 9 (TLR9) in Retinas of Diabetic Rats |
| Q37406985 | Expression of aldehyde dehydrogenase family 1 member A1 and high mobility group box 1 in oropharyngeal squamous cell carcinoma in association with survival time |
| Q64958740 | HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases. |
| Q38830051 | HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism |
| Q34622835 | HMGB1 in health and disease |
| Q37691632 | HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition |
| Q37712279 | HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo |
| Q50090494 | High Expression of High-Mobility Group Box 1 in Menstrual Blood: Implications for Endometriosis |
| Q60907542 | High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway |
| Q36159518 | High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy |
| Q47152534 | High mobility group protein B1 is a predictor of poor survival in ovarian cancer. |
| Q92259954 | High-Mobility Group Box-1-Induced Angiogenesis After Indirect Bypass Surgery in a Chronic Cerebral Hypoperfusion Model |
| Q35045701 | High-mobility group box 1 protein and its role in severe acute pancreatitis |
| Q47099610 | Identification of specifically activated angiogenic molecules in HMGB-1-induced angiogenesis |
| Q38923476 | Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms |
| Q36371453 | Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis |
| Q33358901 | Pattern recognition receptors and DNA repair: starting to put a jigsaw puzzle together |
| Q37582265 | Picroside II protects myocardium from ischemia/reperfusion-induced injury through inhibition of the inflammatory response |
| Q64098308 | Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury |
| Q53548959 | Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction. |
| Q52720171 | Regulation of Tumor Progression by Programmed Necrosis. |
| Q57283116 | The Janus face of HMGB1 in heart disease: a necessary update |
| Q38519934 | The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine. |
| Q38600792 | Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies. |
| Q38784593 | miR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF-κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose |
Search more.